Latest Industry Insights

Exosomes are small vesicles of 30 to 150 nm. To investigate their function there is a need to optimize and standardize the methods employed to isolate exosomes. However, before exploring the different methods, it is worth explaining what makes exosomes so interesting…

The development of GMCTs has been halted by issues surrounding the most critical step in their creation, the introduction of new genetic material. Recently, Indee Labs announced the publication of a study illustrating the efficacy of it's GMCT development and manufacturing technology. We spoke with Indee Labs' CEO Ryan Pawell to learn more about the technology and its applications.

Having reliable antibodies can make or break your assay. However, sourcing the right antibody for the job can sometimes feel like you’re entering the lottery: there are so many on the market, and often they just don’t live up to what was promised. To learn more about antibody validation and its importance, we got in touch with Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology.

Flow cytometry is a technique used to count and analyze the size, shape and properties of individual cells. Not just a valuable research tool, flow cytometry is also finding its stride in several clinical areas. Following BD Biosciences’ launch of a new sample preparation instrument, we spoke to Stephen Gunstream, VP and general manager, to get his insights on the role of flow cytometry in the clinic.

We recently spoke to Charlie Silver, CEO and Co-Founder of Mission Bio, to learn more about how they are helping researchers profile mutational heterogeneity at the single-cell level.

We recently spoke with Dr Lan Huang, CEO at BeyondSpring, a clinical-stage biopharmaceutical company to learn more about the company’s efforts to develop innovative immuno-oncology cancer therapies.

We recently had the pleasure of interviewing award-winning medical physicist Shakar Jafari, PhD. Shakar tells us about her scientific background, her pioneering research exploring the properties of glass bead detectors for measuring radiation, and how this technology could dramatically improve the accuracy of cancer treatment.

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.

Major advances have occurred in the fields of proteomics and genomics over recent years. Now, scientists are utilizing the technologies from each approach collectively in a novel research area named proteogenomics. We spoke with Alexzander Asea, Professor and Director at Precision Therapeutics Proteogenomics Diagnostics Center, University of Toledo, to learn more about the applications of proteogenomics in precision medicine.

Cryoport is the single largest cryogenic delivery system for immunotherapy drugs, and the sole cryogenics logistics provider for the first two commercialized cell therapies. To learn more about the company providing the logistics backbone of clinical trials for regenerative medicine, we caught up with Mark Sawicki, chief commercial officer.